ArticleEuropean radiology2026
Associations between CT characteristics of lung cancer lesions and histologic subtypes in lung cancer screening.
Article in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo assess the associations between imaging characteristics and histologic subtype in screen-detected lung cancers. MATERIALS AND
methodsWe retrospectively analyzed histologically confirmed lung cancers from the NELSON trial. Radiological features (location, margins, nodule type, size, volume, volume doubling time (VDT), pleural distance) were annotated using standardized protocols. Logistic regression adjusted for age, sex, smoking, and stage assessed associations with adenocarcinoma (ADC) versus non-ADC. Sensitivity analyses included models with VDT and were restricted to stage I-II disease.
resultsAmong 213 cancers, 67.5% were ADC and 32.5% non-ADC. Participants were predominantly male (82.4%), with a mean age of 64 years; 73.7% had stage I-II disease. ADCs were more often early stage (86.1% vs 47.8%), smaller (14.6 vs 17.3 mm), and more frequently located in the right upper lobe (49.3% vs 31.9%). In multivariable analysis, larger lesion size was associated with lower odds of ADC (odds ratio (OR) = 0.92, 95% CI 0.85-0.99), while pleural attachment increased the odds (OR = 6.67, 95% CI 1.20-33.33). Compared with the right upper lobe, lesions in the left lower (OR = 0.28), right lower (OR = 0.24), and right middle lobes (OR = 0.17) had lower odds. Model discrimination was acceptable (Area under the curve (AUC) = 0.75), with sensitivity 96% and specificity 29%. In sensitivity analyses, higher VDT was associated with ADC (OR = 5.65), with consistent findings in stage I-II disease.
conclusionIn low-dose computed tomography screening, ADCs are smaller, slower-growing, and more often upper-lobe or pleural-based. These patterns may support improved diagnostic interpretation and personalized nodule management. KEY POINTS: Question Radiological features guide malignancy risk, but their association with histologic subtype in screen-detected lung cancers remains unclear, limiting subtype-specific diagnostic interpretation. Findings Compared to non-adenocarcinomas, adenocarcinomas were smaller, more often pleural-based, and predominantly located in upper lobes, while lower and middle lobe lesions showed lower odds. Clinical relevance Recognizing imaging patterns associated with histologic subtype may improve understanding of tumor biology and inform future multimodal diagnostic approaches.
Indexed as
Identifiers
42844392What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.